Your institution may have access to this item. Find your institution then sign in to continue.
Title
Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non–Small-Cell Lung Cancer
Authors
Lara, Primo N. Jr; Douillard, Jean-Yves; Nakagawa, Kazuhiko; von Pawel, Joachim; McKeage, Mark J.; Albert, Istvan; Losonczy, György; Reck, Martin; Heo, Dae-Seog; Fan, Xiaolin; Fandi, Abderrahim; Scagliotti, Giorgio
Publication
Journal of Clinical Oncology, 2011, Vol 29, Issue 22, p2965